Kartogenin Enhances Chondrogenic Differentiation of iPSC Derived MSCs (iMSCs) and Improves Outcomes in an Osteochondral Defect Model in Male Rats

Documenti analoghi

• Early signs of osteoarthritis in differing rat osteochondral defects
  di: Samir Chihab, et al.
  Pubblicazione: (2024)
• Allogenic MSCs are a safe and efficacious treatment for knee osteoarthritis: A systematic review of randomised controlled trials
  di: Randy Y. J. Loke, et al.
  Pubblicazione: (2025)
• Decellularized Extracellular Matrix Produced by iPSC ‐Derived MSCs Promotes iPSC ‐ MSC Proliferation and Differentiation and Regulates Secreted Factors
  di: Tao Huang, et al.
  Pubblicazione: (2025)
• Medial Osteochondral Defect Drives Matrix and Cell Pathology in Compartment‐Matched Meniscus
  di: Serafina G. Lopez, et al.
  Pubblicazione: (2025)
• Delayed Lubricin Injection Improves Cartilage Repair Tissue Quality in an In Vivo Rabbit Osteochondral Defect Model
  di: Donghwan Yoon, et al.
  Pubblicazione: (2025)